Protection of mammalian cells from severe acute respiratory syndrome coronavirus infection by equine neutralizing antibody.
Immunological Journal(2005)
摘要
The aetiological agent for severe acute respiratory syndrome (SARS) has been determined to be a new type of coronavirus (SARS-CoV) that infects a wide range of mammalian hosts. Up to now, there have been no specific drugs to protect against SARS-CoV infection, thus developing effective strategies against this newly emerged viral infection warrants urgent efforts. Adoptive immune therapy with pathogen-specific heterologous immunoglobulin has been successfully used to control the dissemination of many viral infections. To investigate whether a neutralizing antibody against SARS-CoV raised in an artiodactylous host can have a protective role on primate cells, we prepared serum IgGs and their pepsin-digested F(ab')(2) fragments from horses inoculated with purified SARS-CoV (BJ-01 strain). The protective effect of the F(ab')(2) fragments against SARS-CoV infection was determined in cultured Vero E6 cells by cytopathic effect (CPE), MTT and plaque-forming assays and in a Balb/c mouse model by CPE and quantitative RT-PCR. The results showed the neutralization titres of F(ab'), from three horses all reached at least 1:1600, and 50 mu g of the F(ab'), fragments could completely neutralize 1x10(4) TCID50 SARS-CoV in vivo. Additionally, we observed that F(ab'), against BJ-01 strain could also protect cells from infection by the variant GZ-01 strain in vitro and in vivo. Our work has provided experimental support for testing the protective equine immunoglobulin in future large primate or human trials.
更多查看译文
关键词
Neutralization antibody,SARS-CoV,Equine antiserum,Immunization
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要